For New and Renewal Applications (PHS 398) – DO NOT SUBMIT UNLESS REQUESTED
PHS 398 OTHER SUPPORT
ANDERSON, R.R.
ACTIVE
R01 HL 0000002 (Anderson)
03/1/10– 02/28/16(NCE)
5.60 calendar
NIH/NHLBI5
$186,529
Chloride and Sodium Transport in Airway Epithelial Cells11
The major goals of this project are to define the biochemistry of chloride and sodium transport in airway
epithelial cells and clone the gene(s) involved in transport.12
R01 HL 123456 (Baker)
04/01/12 – 03/31/17
4.20 calendar
NIH/NHLB
$122,717 (sub only)
Ion Transport in Lungs
The major goal of this project is to study chloride and sodium transport in normal and diseased lungs.
PENDING
R01 HL 222222 (Anderson)
12/01/15 – 11/30/20
3.20 calendar
NIH/NHBI
$185,999
Transepithelial sodium and water transport in the lung
The major goals of this project is to study the mechanisms that augment transepithelial sodium transport and
enhance the clearance of alveolar edema may lead to more effective prevention or treatment for pulmonary
edema and acute lung injury
DCB 950000 (Anderson)
12/01/15 – 11/30/20
2.40 calendar
National Science Foundation
$82,163
Liposome Membrane Composition and Function
The major goals of this project are to define biochemical properties of liposome membrane components and
maximize liposome uptake into cells.
OVERLAP
Potential commitment overlap exists. If application under consideration is funded, Dr. Anderson will request
approval to reduce her effort on R01 HL 000000 to 4.00 calendar months. If other pending applications are
funded, Dr. Anderson will reduce her effort appropriately.
HERNANDEZ, M.
ACTIVE
P01 CA 223333 (Chen)
07/01/13 – 06/30/18
3.80 calendar
NIH/NCI
$104,428
Mutations in p53 in Progression of Small Cell Lung Carcinoma
The major goals of this subproject are to define the p53 mutations in SCLC and their contribution to tumor
progression and metastasis.
*The average effort for this budget period is 5 calendar months
P01 CA118816 (Chang)
07/01/12 – 06/30/17
see below
NIH
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
The overall objective of this Program Project Grant (PO1) is to integrate advances in physiologic and metabolic
imaging with ex vivo biological and genetic information obtained from the analysis of image guided tissue
samples in order to optimize the management of patients with glioblastoma (GBM).
Project 1 (Jones)
$371,782
Improved management of GBM by integrating imaging and tissue analysis
0.60 calendar
The goal of this project is to develop and test novel MR metabolic imaging approaches that will help to
distinguish recurrent tumor from normal brain and treatment effects in patients with glioblastoma (GBM).
Project 2 (Murphy)
$308,828
1.20 calendar
Image Guided Genome-Epigenome Analysis of Tumor Heterogeneity and Evolution
Our goal is to identify naturally evolving and treatment-induced mutations and epimutations that promote
the selective outgrowth of malignant subclones over time.
PENDING:
BE 555555 (Hernandez)
12/01/15 – 11/30/20
1.80 calendar
American Cancer Society
$86,732
p53 Mutations in Breast Cancer
The major goals of this project are to define the spectrum of p53 mutations in human breast cancer samples
and correlate the results with clinical outcome.
OVERLAP
There is scientific overlap between aim 2 of ACS BE 00000 and aim 4 of the application under consideration. If
both are funded, the budgets will be adjusted appropriately in conjunction with agency staff.